Loading clinical trials...
Loading clinical trials...
National Blood Pressure Screening in Children to Optimise Clinical Management of Paediatric Hypertension in South Africa
The Childhood Hypertension Consortium of South Africa (CHCSA) was established to foster relationships between the healthcare sector and schools through community engagement and outreach as well as contributing to the decolonization of normative paediatric blood pressure reference values. To date, there has been no nation-wide project in South Africa to determine nationally representative normal blood pressure reference values, nor to estimate the true prevalence of hypertension in the paediatric population of the country. This study will provide critical information on the understanding of blood pressure and hypertension in children, especially of African ancestry. Not only will this effort contribute to the development of the first nationally representative normal reference values of blood pressure but will also benefit healthcare providers in the sector with a clear guideline on the management of high blood pressure in children as developed by experts working with these challenges daily.
Rationale: Currently there exist no nationally representative set of normative reference values for blood pressure and anthropometry in South African children, while clinicians rely on European and US reference values. The latter seems inappropriate in the South African setting, especially considering the lack of data available in African ancestry normative data. Objectives: The investigators aim to development the first nationally representative normal reference values of blood pressure and anthropometry in children, to develop scientific evidence-based hypertension guidelines in the paediatric population of South Africa. Methods: The target population for this study includes 5 to under 18 years school-aged (all school quintiles) children in South Africa from all provinces in the country selected in a randomized manner and to ensure generalizability. Population: A sample of 22 464 (81% Black African; 9% Coloured; 8% White and 2% Indian/Asian) will be required to enable computation of reference values for each age and sex across urban, peri-urban and rural settings in all provinces. Time frame: The study will recruit and collect data over a period of five years. Expected outcomes: The investigators expect that normative blood pressure in children (ages above 5 and under 18 years) will differ from currently accepted international thresholds. The investigators will engage in the communities to optimise awareness and care of high blood pressure and its comorbidities. Recommendations will be made to the National Department of Health regarding blood pressure measurement/screening for hypertension in children at the local clinic in the Road to Health booklet. The investigators will also develop the first clinical practice guidelines for the management of hypertension in children in South Africa in collaboration with hypertension societies.
Age
5 - 18 years
Sex
ALL
Healthy Volunteers
Yes
Walter Sisulu University
Mthatha, Eastern Cape, South Africa
Nelson Mandela Metropolitan University
Port Elizabeth, Eastern Cape, South Africa
University of the Free State
Bloemfontein, Free State, South Africa
University of the Witwatersrand
Johannesburg, Gauteng, South Africa
University of KwaZulu-Natal
Durban, KwaZulu-Natal, South Africa
University of Limpopo
Polokwane, Limpopo, South Africa
Hypertension in Africa Research Team (HART), North-West University
Potchefstroom, North West, South Africa
Red Cross War Memorial Children Hospital
Cape Town, Western Cape, South Africa
South African Medical Research Council
Cape Town, Western Cape, South Africa
University of Cape Town
Cape Town, Western Cape, South Africa
Start Date
April 1, 2024
Primary Completion Date
November 30, 2028
Completion Date
November 30, 2028
Last Updated
September 5, 2024
22,464
ESTIMATED participants
Blood pressure screening
DIAGNOSTIC_TEST
Lead Sponsor
North-West University, South Africa
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions